Dr Ing Financials
| P911 Stock | 57.98 0.84 1.47% |
P911 |
Understanding current and past Dr Ing Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Dr Ing's financial statements are interrelated, with each one affecting the others. For example, an increase in Dr Ing's assets may result in an increase in income on the income statement.
| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | DE000PAG9113 |
| Business Address | Porscheplatz 1, Stuttgart, |
| Sector | Consumer Cyclical |
| Industry | Auto Manufacturers |
| Benchmark | Dow Jones Industrial |
| Website | www.porsche.com/international |
| Phone | 49 711 911 0 |
P911 Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Dr Ing's current stock value. Our valuation model uses many indicators to compare Dr Ing value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Dr Ing competition to find correlations between indicators driving Dr Ing's intrinsic value. More Info.Dr Ing hcF is considered to be number one stock in profit margin category among its peers. It also is considered to be number one stock in operating margin category among its peers reporting about 1.45 of Operating Margin per Profit Margin. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Dr Ing's earnings, one of the primary drivers of an investment's value.Dr Ing hcF Systematic Risk
Dr Ing's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Dr Ing volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Dr Ing hcF correlated with the market. If Beta is less than 0 Dr Ing generally moves in the opposite direction as compared to the market. If Dr Ing Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Dr Ing hcF is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Dr Ing is generally in the same direction as the market. If Beta > 1 Dr Ing moves generally in the same direction as, but more than the movement of the benchmark.
Dr Ing November 24, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Dr Ing help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Dr Ing hcF. We use our internally-developed statistical techniques to arrive at the intrinsic value of Dr Ing hcF based on widely used predictive technical indicators. In general, we focus on analyzing P911 Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Dr Ing's daily price indicators and compare them against related drivers.
| Information Ratio | (0.19) | |||
| Maximum Drawdown | 9.81 | |||
| Value At Risk | (4.35) | |||
| Potential Upside | 3.36 |
Complementary Tools for P911 Stock analysis
When running Dr Ing's price analysis, check to measure Dr Ing's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Ing is operating at the current time. Most of Dr Ing's value examination focuses on studying past and present price action to predict the probability of Dr Ing's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Ing's price. Additionally, you may evaluate how the addition of Dr Ing to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |